Overview
George Wiggins practices practicing medicine in Christchurch, New Zealand.
His clinical expertise encompasses Cerebral Hypoxia, Breast Cancer, Ovarian Cancer, and Glioma.
He is actively involved in clinical research, co-authoring 24 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about George R. Wiggins
Is George R. Wiggins a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. George R. Wiggins is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does George R. Wiggins participate in research or clinical trials?
Yes. George R. Wiggins has published 24 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of George R. Wiggins's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMr. Wiggins isExperienced. Learn about Breast Cancer.
- Cerebral HypoxiaMr. Wiggins isExperienced. Learn about Cerebral Hypoxia.
- GliomaMr. Wiggins isExperienced. Learn about Glioma.
- Ovarian CancerMr. Wiggins isExperienced. Learn about Ovarian Cancer.